HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
IMNM
Immunome Inc
Healthcare Biotechnology · Pennsylvania, USA · Reports in usd
Market Cap: $3.10B
Market Cap
$3.10B
Enterprise Val
$2.59B
P/E Ratio
-12.20
P/B Ratio
5.91
Trailing PEG (1Y)
-0.41
As Of
Aug 16, 2026

Overview & Key Metrics

Reporting period: Jun 30, 2026 · Q2 2026
Book Value$525.1M
Return on Equity-50.56%
Return on Assets-46.93%
Current Ratio15.08
Debt/Equity0.01
LT Debt/Equity0.01
Revenue Per Share0.00

Income Statement

Jun 30, 2026
Revenue$0.00
Cost of Revenue$0.00
Gross Profit$0.00
R&D$59.9M
SG&A$18.3M
Operating Expenses$78.1M
Operating Income-$78.1M
Interest Expense$0.00
Tax Expense$0.00
Net Income-$73.1M
EPS (Basic)$-0.65
EPS (Diluted)$-0.65
EBIT-$73.1M
EBITDA-$72.0M
Consolidated Income-$73.1M
Non-Controlling Interests$0.00

Balance Sheet

Jun 30, 2026
Cash & Equivalents$217.9M
Accounts Receivable$0.00
Inventory$0.00
Current Assets$538.4M
LT Investments$0.00
Property, Plant & Equipment$21.3M
Intangibles$0.00
Non-Current Assets$26.9M
Total Assets$565.4M
Accounts Payable$6.0M
Current Debt$0.00
Current Liabilities$35.7M
LT Debt$4.6M
Non-Current Liabilities$4.6M
Total Liabilities$40.3M
Total Debt$4.6M
Retained Earnings-$855.1M
Shareholder Equity$525.1M
Shares Outstanding113,250,394

Cash Flow Statement

Jun 30, 2026
Operating Cash Flow-$61.7M
Investing Cash Flow-$304.4M
Financing Cash Flow$1.1M
CapEx-$2.2M
Free Cash Flow-$63.9M
Depreciation & Amort.$1.2M
Stock-Based Comp$8.8M
Acquisitions / Disposals$0.00
Investment Activity-$302.2M
Debt Issued/Repaid$0.00
Equity Issued/Repaid$1.1M
Dividends Paid$0.00
Net Change in Cash-$365.0M
Data cached · Meta live · Daily live · Statements live · TTL 24h